The Vaccentis roadshow with 8 Hours Ahead in Hong Kong and China in May 2025 was a great success. With the facilitation of the 8 Hours Ahead team Jake Watkin 华德金, Xian (Carrie) Wu and Marco Wai our CEO Martin Munte and our Head of R&D and CMO Ingrid Rauter were able to meet many important investor contacts with global and China backgrounds as well as government representatives to present Vaccentis and its key strategy to develop individualized therapeutic tumor vaccines.
